Morgan Stanley’s Lixte Biotechnology LIXT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $24K | Sell |
|
|||||
|
2023
Q4 | $33.4K | Buy |
|
|||||
|
2023
Q3 | $17.4K | Hold |
|
|||||
|
2023
Q2 | $41.8K | Buy |
|
|||||
|
2023
Q1 | $58.8K | Hold |
|
|||||
|
2022
Q4 | $36.2K | Hold |
|
|||||
|
2022
Q3 | $40K | Hold |
|
|||||
|
2022
Q2 | $53K | Hold |
|
|||||
|
2022
Q1 | $87K | Hold |
|
|||||
|
2021
Q4 | $85K | Hold |
|
|||||
|
2021
Q3 | $148K | Hold |
|
|||||
|
2021
Q2 | $215K | Buy |
|
|||||
|
2021
Q1 | $69K | Buy |
|